98%
921
2 minutes
20
Background: Endocrine-disrupting chemicals (EDC) found in many household and personal care products have hormonal properties and effects on the mammary gland. It is unclear whether urinary concentrations of EDCs are associated with higher percent breast density, a major risk factor of breast cancer.
Methods: We conducted a cross-sectional study of 97 college-aged women. We quantified individual levels of bisphenol A, bisphenol S, bisphenol F, triclosan, triclocarban, 3-benzophenone, seven phthalate metabolites, four parabens, and two other phenols in three 24-hour urine samples combined into a single pooled sample. Each woman had non-enhanced MRI to assess percent breast density. Associations between estimated concentrations of individual EDCs and percent breast density were analyzed using adjusted linear regression.
Results: There was no evidence of a statistically significant increase in mean percent breast density in the middle or highest tertile for any EDC measured. There was a suggestion that the mean percent breast density was elevated in individuals in the middle and highest tertile levels of ethyl paraben compared with those in the lowest tertile, with a relative increase in mean percent breast density of 16% (β = 1.16; 95% CI, 0.92-1.46) in tertile 2 and 24% (β = 1.24; 95% CI, 0.99-1.57) in tertile 3, relative to tertile 1 (Ptrend = 0.07). Similar trends in percent breast density were observed for methylparaben, propylparaben, and butylparaben.
Conclusions: Urinary levels of EDCs were not associated with percent breast density in college-aged women.
Impact: The estimated effect of EDCs on the breast tissue of young women is unclear and warrants larger studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316558 | PMC |
http://dx.doi.org/10.1158/1055-9965.EPI-24-1694 | DOI Listing |
ACS Nano
September 2025
Department of Chemistry, Queen Mary University of London, Mile End Road, London E1 4NS, United Kingdom.
Nanoscale organization of integrin-mediated receptor crosstalk is crucial for controlling cellular signaling in cancer biology. Previously, interactions between integrin αvβ6 and receptor tyrosine kinases (RTKs) have been implicated in cancer progression, but the spatial regulatory mechanisms remain undefined. Here, we developed a programmable DNA origami-based platform for nanoscale control of heteroligand multivalency and spacing, enabling systematic investigation of αvβ6-RTK interactions in cancer biology.
View Article and Find Full Text PDFAdv Pharm Bull
July 2025
Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Purpose: Tumor hypoxia is a key barrier to successful delivery and activity of anti-cancer agents. To tackle this, we designed hypoxia-responsive Au-PEI-Azo-mPEG nanoparticles (NPs) denoted as APAP NPs for targeted delivery of hypoxia-activated prodrug (HAP), tirapazamine (TPZ) to hypoxic breast cancer cells.
Methods: AuNPs were first synthesized.
J Ethn Subst Abuse
September 2025
Başakşehir Çam and Sakura Hospital, Istanbul, Turkey.
This study was conducted in a descriptive and cross-sectional design to determine the physical health status of individuals with substance use disorders receiving inpatient treatment at an addiction treatment center. Data were collected between April 2023 and April 2024 at the Adult Detoxification Center of a psychiatric hospital in Istanbul, Türkiye. The sample consisted of a total of 261 individuals with substance use disorders (218 males and 43 females) who met the inclusion criteria.
View Article and Find Full Text PDFMedicine (Baltimore)
September 2025
Department of Breast Surgery, Weifang People's Hospital, Weifang, Shandong Province, People's Republic of China.
The presence of androgen receptor (AR) as a marker can be detected in all breast cancer subtypes, and it may provide information on treatment response and prognosis. This study aimed to examine the correlation between AR expression and treatment response in patients diagnosed with human epidermal growth factor receptor 2 (HER2) positive breast cancer who were undergoing neoadjuvant therapy (NAT). The evaluation included breast cancer patients who received NAT and underwent surgery at Weifang People's Hospital's Department of Breast Surgery between October 2019 and October 2022.
View Article and Find Full Text PDFBMJ Open Diabetes Res Care
September 2025
Department of Social Medicine and Health Management, Huazhong University of Science and Technology School of Public Health, Wuhan, Hubei, China
Introduction: To examine the association of the number of controlled risk factors with the excess risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD) and major adverse liver outcomes (MALO) among patients with type 2 diabetes.
Research Design And Methods: In this cohort study, a total of 307,688 participants from the UK Biobank were included. Participants with baseline type 2 diabetes were categorized according to the number of risk factors within the guideline-recommended ranges (diet, smoking, drinking, exercise, sedentary behavior, body mass index, glycated hemoglobin, blood pressure, and low-density lipoprotein cholesterol).